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Health-Related Quality of Life Using the EuroQol 5D 
Questionnaire in Korean Patients with Type 2 Diabetes
We aimed; 1) to determine the validity of the EuroQol 5D (EQ-5D) for the health-related 
quality of life (HRQOL) of Korean patients with type 2 diabetes, and 2) to identify 
associated factors of the HRQOL of these patients. Follow-up surveys were conducted for 
consecutive patients with type 2 diabetes. HRQOL was assessed using the EQ-5D and the 
Short Form-36 (SF-36). The validity of EQ-5D was assessed with the perspectives of known 
group, convergent and discriminant validity. Additionally, a linear mixed model using a 
backward elimination was used for identify associated factors. Of the 1,072 patients 
included in the first survey, 858 (80.0%) completed the questionnaires in the follow-up. In 
the known group validity, the problem rates in each EQ-5D dimension were highest among 
women, elderly people, and less-educated subjects. The Spearman’s ρ between the EQ-5D 
and the SF-36 scales were larger in the comparable dimensions than those in the less 
comparable dimensions. In the final model, we found that sex, age, education, body mass 
index, atrial fibrillation, stroke, and retinopathy were statistically significant. Our data 
suggest that the EQ-5D is a valid tool for Korean patients with type 2 diabetes and that 
various factors could affect their HRQOL.
Key Words: EQ-5D; Health-Related Quality of Life; Diabetes Mellitus, Type 2
Woo Je Lee
1, Kee-Ho Song
2, 
Jung Hyun Noh
3, Yon Jong Choi
4, 
and Min-Woo Jo
5 
1Department of Internal Medicine, University of 
Ulsan College of Medicine, Seoul; 
2Department of 
Internal Medicine, Konkuk University School of 
Medicine, Seoul; 
3Department of Internal Medicine, 
Ilsan Paik Hospital, Inje University College of 
Medicine, Goyang; 
4Department of Regulatory 
Affairs & Market Access, Sanofi-Aventis Korea Co. 
Ltd., Seoul; 
5Department of Preventive Medicine, 
University of Ulsan College of Medicine, Seoul, Korea
Received: 19 October 2011
Accepted: 2 January 2012
Address for Correspondence:
Min-Woo Jo, MD
Department of Preventive Medicine, University of Ulsan College 
of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, 
Korea
Tel: +82.2-3010-4264, Fax: +82.2-477-2898
Email: mdjominwoo@paran.com 
http://dx.doi.org/10.3346/jkms.2012.27.3.255  •  J Korean Med Sci 2012; 27: 255-260
ORIGINAL ARTICLE
Endocrinology, Nutrition & Metabolism
INTRODUCTION
Health policies for non-communicable diseases should include 
strategies for the management of type 2 diabetes, as this disease 
has become more common worldwide and remains an impor-
tant risk factor for cardiovascular diseases. The International 
Diabetes Federation estimates that 333 million people will have 
diabetes by 2025 (1). In the USA, the prevalence of diabetes in-
creased from 5.3% to 8.2% between 1980 and 2000 (2). In Korea, 
the prevalence of diabetes (aged ≥ 30 yr) was estimated to be 
9.1% in 2005 (3, 4).
  In analyzing the health impact of chronic diseases, health-
related quality of life (HRQOL) has been commonly used as an 
outcome indicator because patient cooperation forms the core 
of health plans for incurable diseases. The quality-adjusted life 
years (QALYs) is defined as a measure of a person’s length of life 
weighted by a valuation of their HRQOL and a valuable outcome 
measure of disease burden. The QALYs can be used in clinical 
practice, trials, economic evaluation, and health policy formu-
lation. 
  The EuroQol 5D (EQ-5D), a generic measure of HRQOL, is 
widely used to determine the utility weight to measure decreases 
in QALYs due to disease. Some studies have used EQ-5D to esti-
mate the HRQOL of type 2 diabetic patients in Western and Asian 
countries. Clarke et al. (5) reported that the EQ-5Dindex is an in-
dependent predictor of mortality risk, future vascular events, 
and other complications in patients with type 2 diabetes. Saka-
maki et al. (6) reported HRQOL in Japanese patients with type 2 
diabetes using EQ-5D, and Sakthong et al. (7) estimated the EQ-
5Dindex in Thai patients with type 2 diabetes. However, in these 
studies, the HRQOL has been assessed by cross-sectional de-
sign. Because HRQOL is a time-dependent variable, repeated 
measurements are required to obtain reliable estimates. In ad-
dition, the Korean version of EQ-5D has not been validated for 
use in patients with type 2 diabetes in Korea. 
  The aim of this study was to assess the validity of the Korean 
version of EQ-5D to evaluate the HRQOL of Korean patients 
with type 2 diabetes, and also to identify associated factors to 
the HRQOL of these patients during follow-up surveys.
MATERIALS AND METHODS
Subjects
Consecutive patients with type 2 diabetes who routinely visited 
the outpatient clinics of three university hospitals (i.e., Sanggye 
Paik Hospital and Konkuk University Hospital in Seoul, and Ilsan Lee WJ, et al.  •  HRQOL in Koreans with Type 2 Diabetes
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Paik Hospital in Gyeonggi Province) were invited to participate 
in the first survey (October 2007-January 2008). Participants 
completed all the questionnaires in the clinic on the day of re-
cruitment to the first survey. 
  Subjects were included in the study if they were > 20-yr-old 
and had a confirmed diagnosis and/or received ongoing treat-
ment for type 2 diabetes. The exclusion criteria were type 1 dia-
betes, a history of not taking relevant treatments, and unwilling-
ness to participate in the study. During subsequent follow-up 
visits, subjects who participated in the first survey were invited 
to complete a second survey from December 2007 to April 2008 
using same methods. All surveys were conducted by well-trained 
research nurses.
Information
The following information was recorded during interviews and 
by reviewing the medical charts: general characteristics of the 
subjects, including sex, age, education, marital status, drinking 
and smoking status; and clinical factors such as weight, height, 
treatment modality, comorbidities (e.g., hypertension, hyper-
lipidemia, atrial fibrillation [AF], and cataracts); macrovascular 
complications such as acute myocardial infarction, angina pec-
toris, acute stroke, and transient ischemic attack (TIA); and mi-
crovascular complications such as retinopathy and nephropa-
thy. The subjects’ HRQOL was assessed using the EQ-5D. In the 
first survey, the Short Form (SF)-36 was used to validate the EQ-
5D. EQ-5Dindex was calculated using Korean valuation set (8). 
Validity of the EQ-5D for evaluation of Korean patients 
with type 2 diabetes 
The known group construct, convergent, and discriminant valid-
ities of the EQ-5D were examined. The known group construct 
validity was determined by comparing the rates of reported prob-
lem pertaining to each EQ-5D dimension among different groups 
based on sex, age, and education. We expected the rates to be 
higher among women, older individuals, and less-educated 
patients. To evaluate the convergent and discriminant validity, 
we examined the correlation coefficients between the EQ-5D 
and the eight scale scores and two summary scores of the SF-36. 
Our hypothesis was a greater correlation between the SF-36 
scales and the EQ-5D dimensions that represent similar char-
acteristics (e.g., the mobility dimension of EQ-5D and the phys-
ical functioning [PF] scale of SF-36) than between less compa-
rable scales and dimensions, such as the mobility of EQ-5D and 
the mental health (MH) scale of SF-36.
 
Statistical analysis
Student’s t-tests or ANOVA and chi-square tests were performed 
to compare the characteristics of study participants of the first 
and second surveys and HRQOL on general characteristics. In 
addition, Student’s t-test was used to examine the mean differ-
ence in SF-36 scale scores with regards to EQ-5D dimensions. 
Spearman’s correlation coefficients were calculated between 
the EQ-5D and the SF-36. The agreement of problems in the 
EQ-5D dimension was analyzed by Cohen’s kappa value. We 
examined the effect of each general and clinical characteristic 
on the HRQOL of patients with type 2 diabetes using a linear 
mixed model and backward eliminations were used for variable 
selections. Analyses were performed with PASW statistical soft-
ware 18.0 (SPSS Inc., Chicago, IL, USA) with a P value < 0.05 
considered statistically significant.
Ethics statement 
The study protocol was approved by the institutional review 
board of each participating hospital (IRB No. #07-35 in the Sang-
gye Paik Hospital; KUH 1010058 in the Konkuk University Hos-
pital; and IB-0709-056 in the Ilsan Paik Hospital). And informed 
consent was obtained from all patients.  
RESULTS
General and clinical characteristics of the study participants
The characteristics of the subjects are shown in Table 1. Of the 
1,072 patients with type 2 diabetes who completed the first sur-
vey, 581 (54.2%) were men. Of the 858 patients who completed 
the second survey 473 (55.1%) were men. The follow-up rate was 
80.0%. The mean ages of the patients who completed the first 
and second surveys were 57.5 and 57.7 yr, respectively. Educa-
tion was classified as follows (percentages in the parentheses 
correspond with the first and second surveys, respectively): “el-
ementary school or below” (25.2% and 25.7%), “middle or high 
school” (49.6% and 49.7%), and “university or above” (25.1% 
and 24.6%). The mean BMI was 24.9 kg/m
2 in the first survey 
and 25.0 kg/m
2 in the second survey. A total of 431 (40.2%, first 
survey) and 338 (39.4%, second survey) patients were treated 
with diet therapy; 864 (80.7%) and 693 (80.8%), with oral hypo-
glycemic agents; and 282 (26.3%) and 234 (27.3%), with insulin 
therapy (including patients receiving both insulin and oral hy-
poglycemic agents). No significant differences in general char-
acteristics were observed between the two groups.
  Hypertension (55.3% and 55.8%) and hyperlipidemia (53.5% 
and 54.1%) were the most frequent comorbidities. Angina pec-
toris (8.3% and 8.9%) and ischemic stroke (5.6% and 6.1%) were 
frequent macrovascular complications. Furthermore, 23.6% and 
24.4% of the patients had retinopathy and 4.6% and 7.2% of the 
patients had nephropathy in the first and second surveys, respec-
tively. No significant differences were noted in the proportion 
of complications between the first and second surveys.
Validity
As expected in the known group construct, the HRQOL signifi-
cantly differed with sex, age, and education (P < 0.01). In addi-Lee WJ, et al.  •  HRQOL in Koreans with Type 2 Diabetes
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tion, the EQ-5Dindex was lower in women than in men, and scores 
were higher in younger than in older subjects. Patients in the 
elementary school or below group had lower EQ-5Dindex scores 
than those in the middle/high school and university or above 
groups (Table 2).
  As results from convergent and discriminant validity analysis, 
most mean differences of SF-36 scale scores were statistically 
significant according to problem reporting of each EQ-5D dimen-
sion (Fig. 1). The difference of PF scale score in patients on mo-
bility problem reporting (32.2), as determined using EQ-5D, was 
larger than the difference of MH scale scores (14.2). In addition, 
the difference of MH scale scores of patients on anxiety/depres-
sion of EQ-5D was 25.5, while the difference of PF scale score on 
problem reporting in anxiety/depression was 14.9. Table 3 showed 
the spearman’s correlation coefficients between the EQ-5D and 
the SF-36. The coefficients were larger between related dimen-
sions (e.g., -0.462 between mobility in EQ-5D and physical func-
tioning [PF] in SF-36 and -0.652 between pain/discomfort in 
EQ-5D and bodily pain [BP] in SF-36) than unrelated dimen-
sions (e.g. -0.201 between mobility in EQ-5D and mental health 
[MH] in SF-36). 
Differences of problem rates in each EQ-5D dimension 
between the surveys
Some differences were found in the rates of problems, as assessed 
according to the EQ-5D dimensions between two surveys (Table 
4). We found that 7.0% of the subjects reported a change in the 
self-care dimension, and 19.2% of people reported a change in 
the pain/discomfort dimension.
Associated factors to utility of type 2 diabetes patients
In the univariate model, most variables were significantly related 
with the HRQOL of Korean type 2 diabetes patients except for 
hyperlipidemia, MI, and nephropathy. The final multivariate 
model included sex, age, BMI, AF, ischemic stroke, and retinop-
athy (Table 5). The absolute values of β coefficients on age groups 
(0.025 to 0.0597) were larger than those values of sex (0.0225) 
and education (0.017 to 0.0289). In clinical factors, the β coeffi-
cient of AF was the largest (-0.0751) and followed by ischemic 
stroke (-0.0541), BMI group (0.0315 to 0.0448) and retinopathy 
(-0.021). 
Table 1. Characteristics of the study population
Parameters First survey Second survey P
Number of patients 1,072 858  
Men 581 (54.2%) 473 (55.1%) 0.8
Age (yr)
   Mean ± SD
   Minimum, maximum
 
57.5 ± 12.1
23, 86
 
57.7 ± 12.0
23, 86
 
0.7
Education
   Elementary school or below
   Middle or high school
   University or above
  
270 (25.2%)
531 (49.6%)
269 (25.1%)
  
220 (25.7%)
426 (49.7%)
211 (24.6%)
0.9
BMI (kg/m
2)
   Mean ± SD
   < 18.5
   18.5-24.9
   25.0-29.9
   ≥ 30
 
24.9 ± 3.5
26 (2.4%)
565 (52.7%)
401 (37.4%)
80 (7.5%)
 
25.0 ± 3.5
21 (2.4%)
448 (52.2%)
325 (37.9%)
64 (7.5%)
 
0.8
 
 
 
1.0
Alcohol drinking 380 (35.4%) 299 (34.8%) 0.9
Current smoking 248 (23.2%) 198 (23.1%) 0.8
Treatment
   Diet
   Oral hypoglycemic agents
   Insulin
   Oral hypoglycemic 
      agents + Insulin 
   Complementary & 
      alternative medicine
 
431 (40.2%)
864 (80.7%)
282 (26.3%)
139 (13.0%)
56 (5.2%)
 
338 (39.4%)
693 (80.8%)
234 (27.3%)
117 (13.7%)
40 (4.7%)
 
0.7
0.9
0.6
0.6
0.6
Clinical factors
   Hypertension
   Hyperlipidemia
   Myocardial infarction
   Angina pectoris
   Congestive heart failure
   Atrial fibrillation
   Ischemic stroke
   Transient ischemic attack 
   Retinopathy
   Cataract
   Nephropathy
  
582 (55.3%)
564 (53.5%)
50 (4.7%)
87 (8.3%)
46 (4.4%)
21 (2.0%)
60 (5.6%)
18 (1.7%)
253 (23.6%)
253 (21.6%)
39 (4.6%)
  
469 (55.8%)
455 (54.1%)
42 (5.0%)
75 (8.9%)
36 (4.3%)
15 (1.8%)
52 (6.1%)
15 (1.8%)
209 (24.4%)
184 (21.5%)
32 (7.2%)
  
0.8
0.9
0.7
0.6
0.9
0.7
0.7
0.9
0.2
1.0
0.7
Table 2. Problems in each of the EQ-5D dimension and EQ-5Dindex  according to general characteristics
Parameters Mobility Self-care Usual activities Pain/discomfort Anxiety/depression  Mean EQ-5Dindex 
Sex
   Male
   Female
 
15.5%
24.8%*
 
6.0%
10.0%*
 
13.6%
21.6%*
 
28.2%
42.8%*
 
17.9%
32.4%*
 
0.9365 (0.0046)
0.9023 (0.0052)*
Age (yr)
   ≤ 39
   40-49
   50-59
   60-69
  ≥ 70
 
8.5%
9.8%
13.6%
22.3%
40.5%*
 
2.4%
3.4%
7.0%
9.2%
14.1%*
 
7.3%
11.2%
11.7%
21.1%
27.6%*
 
20.7%
28.8%
31.1%
37.9%
48.1%*
 
20.7%
25.4%
26.0%
23.2%
25.4%*
 
0.9535 (0.0089)
0.9349 (0.0096)
0.9318 (0.0062)
0.9152 (0.0059)
0.8847 (0.0092)*
Education
   Elementary school or below
   Middle or high school
   University or above
 
31.5%
17.1%
13.4%*
 
11.9%
7.5%
4.5%*
 
26.7%
15.8%
10.8%*
 
48.1%
33.1%
25.3%*
 
30.4%
24.7%
18.6%*
 
0.8913 (0.0074)
0.9235 (0.0052)
0.9463 (0.0051)*
Mean EQ-5Dindex data are shown as means (standard error). *P < 0.01. Lee WJ, et al.  •  HRQOL in Koreans with Type 2 Diabetes
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DISCUSSION
Our findings reveal that the EQ-5D is a useful tool measuring 
the HRQOL of Korean patients with type 2 diabetes. In addition, 
we found that comorbidities such as obesity and AF and com-
plications such as ischemic stroke and retinopathy significantly 
affected the HRQOL of these patients. The sex, age and educa-
tion were also important factors to HRQOL of Korean type 2 di-
abetes patients.
  Previous studies have reported that certain medical condi-
tions hamper the HRQOL of patients with type 2 diabetes. Re-
dekop et al. (9) and Lee et al. (10) reported that obesity signifi-
cantly reduces the HRQOL of patients with type 2 diabetes, as 
measured using the EQ-5D. Using the Self-Administered Quali-
ty of Well Being index, Coffey et al. (11) reported that the major 
complications of diabetes are associated with low HRQOL. In 
addition, Sakamaki et al. (6) found a negative association be-
tween the major complications of type 2 diabetes and HRQOL, 
but this association was statistically insignificant except in the 
Fig. 1. Differences in eight SF-36 scales with regards to reports of “no problems” and “some or severe problems” in each EQ-5D domain. *P < 0.05. PF, physical functioning; 
RP, role-physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role-emotional; MH, mental health. 
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Table 3. Spearman’s correlation coefficients between EQ-5D and SF-36
EQ-5D
SF-36
Physical 
functioning
Role- 
physical
 Bodily  
 pain
General  
health
Vitality
Social  
functioning
Role- 
emotional
Mental 
health
Physical  
component 
summary
Mental  
component 
summary
Mobility Spearman’s rho
P
-0.462
< 0.001
-0.362
< 0.001
-0.422
< 0.001
-0.276
< 0.001
-0.321
< 0.001
-0.258
< 0.001
-0.216
< 0.001
-0.201
< 0.001
-0.484
< 0.001
-0.158
< 0.001
Self-care Spearman’s rho
P
-0.340
< 0.001
-0.292
< 0.001
-0.290
< 0.001
-0.191
< 0.001
-0.227
< 0.001
-0.266
< 0.001
-0.170
< 0.001
-0.153
< 0.001
-0.338
< 0.001
-0.138
< 0.001
Usual activity Spearman’s rho
P
-0.440
< 0.001
-0.408
< 0.001
-0.405
< 0.001
-0.271
< 0.001
-0.346
< 0.001
-0.384
< 0.001
-0.339
< 0.001
-0.269
< 0.001
-0.442
< 0.001
-0.286
< 0.001
Pain/discomfort Spearman’s rho
P
-0.435
< 0.001
-0.388
< 0.001
-0.652
< 0.001
-0.368
< 0.001
-0.388
< 0.001
-0.394
< 0.001
-0.324
< 0.001
-0.342
< 0.001
-0.528
< 0.001
-0.312
< 0.001
Anxiety/depression Spearman’s rho
P
-0.279
< 0.001
-0.287
< 0.001
-0.333
< 0.001
-0.328
< 0.001
-0.354
< 0.001
-0.317
< 0.001
-0.395
< 0.001
-0.477
< 0.001
-0.237
< 0.001
-0.464
< 0.001
Table 4. Respondent numbers reporting problems in EQ-5D dimensions on the first 
and second surveys
The first survey
The second survey
No problem, 
No (%)
Some or  
severe  
problems,  
No (%)
Kappa 
value
Mobility
   No problem
   Some or severe problems
 
654 (76.2)
78 (9.1)
 
38 (4.4)
88 (10.3)
 
0.523*
 
Self-care
   No problem
   Some or severe problems
 
768 (89.5)
34 (4.0)
 
26 (3.0)
30 (3.5)
 
0.463*
 
Usual activities
   No problem
   Some or severe problems
 
665 (77.5)
63 (7.3)
 
45 (5.2)
85 (9.9)
 
0.537*
Pain/discomfort
   No problem
   Some or severe problems
 
504 (58.7)
104 (12.1)
 
61 (7.1)
189 (22.0)
 
0.557*
Anxiety/depression
   No problem
   Some or severe problems
 
591 (68.9)
80 (9.3)
 
73 (8.5)
114 (13.3)
 
0.484*
*P < 0.001. Lee WJ, et al.  •  HRQOL in Koreans with Type 2 Diabetes
http://jkms.org   259 http://dx.doi.org/10.3346/jkms.2012.27.3.255
case of certain subjective symptoms. The authors proposed that 
this finding resulted from the exclusion of patients with severe 
disease. Consistent with this suggestion, our patients were also 
recruited from outpatient clinics; hence, the impacts of comor-
bidities and complications on EQ-5Dindex were relatively low.
  Validity was assessed in terms of three aspects, and was found 
to match our expectations. With regards to convergent validity, 
there were considerable differences in the PF, RP, BP, and SF 
scale scores on the SF-36 compared with subjects’ scores on the 
EQ-5D dimensions of mobility, self-care, routine activity (i.e., 
all three are related to physical ability). Furthermore, there were 
notable correlation between BP scores of the SF-36 and pain/
discomfort scores of the EQ-5D, as well as between the RE scale 
scores on the SF-36 and the anxiety/depression dimension of 
the EQ-5D. Therefore, we could conclude that the convergent 
validity of the EQ-5D is acceptable. The age and sex distributions 
of the EQ-5Dindex were also similar to expected values. Most items 
received lower scores in women and elderly subjects. Therefore, 
our data suggest that the EQ-5D could be a valid and acceptable 
method of evaluating the HRQOL of Korean patients with type 
2 diabetes.
  In this study, there were some differences in the HRQOLs of 
Korean patients with type 2 diabetes between the surveys. These 
findings show that the HRQOL is a time-dependent variable, 
and should be repeatedly measured in type 2 diabetic patients 
to ensure reliable estimations. In addition, because changes in 
HRQOL may have caused patients to discontinue follow-up, 
the actual change in HRQOL may have been greater than esti-
mated in the current study.
  There are three valuation sets for the Korean version of the EQ-
5D. We used the valuation set reported by Jo et al. (8) because 
this set was calculated from general populations in Seoul and 
Gyeonggi province. Although we did not represent the results 
using the other valuation sets (12-14) in this paper, the coeffi-
cients in the models differ according to the valuation sets. These 
findings indicate that valuation sets could affect the results of 
utility studies; so sensitivity analyses should be conducted us-
ing data from other Korean studies.
  This study has limitation in terms of the representativeness of 
the study population because we did not randomly recruit study 
participants. However, our study population was derived from 
three institutes in diverse regions. Also, the mean age and sex 
distributions of our patients were similar to those in previous 
population-oriented utilization studies of patients with diabe-
tes in Korea (15). 
  In conclusion, our findings suggest that EQ-5D is a valid tool 
Table 5. Univariate and multivariate models
Variables
Univariate model Multivariate model
β (standard error) P β (standard error) P
Intercept - - 0.8445 (0.0196) < 0.001
Male sex -0.0355 (0.0062) < 0.001 -0.0225 (0.0077) 0.003
Age (yr)
   ≤ 39
   40-49
   50-59
   60-69
   > 70
 
0.0680 (0.0133) 
0.0558 (0.0102)
0.0472 (0.0096)
0.0261 (0.0093)
-
 
< 0.001
< 0.001
< 0.001
0.005
-
   
0.0597 (0.0159)
0.0375 (0.0120)
0.0405 (0.0111)
0.0250 (0.0105)
-
 
< 0.001
0.002
< 0.001
0.018
-
 
Education
   Elementary school or below
   Middle or high school
   University or above
 
-0.0571 (0.0087)
-0.0220 (0.0075)
-
 
< 0.001
0.004
-
   
-0.0289 (0.0112)
-0.0170 (0.0088)
-
 
0.010
0.053
-
BMI
   < 18.5
   18.5-24.9
   25.0-29.9
   ≥ 30
 
0.0271 (0.0114)
0.0309 (0.0122)
0.0229 (0.0125)
-
 
0.241
0.012
0.068
-
 
0.0416 (0.0267)
0.0448 (0.0141)
0.0315 (0.0144)
-
 
0.120
0.002
0.029
-
Hypertension -0.0203 (0.0063) 0.001 - -
Hyperlipidemia -0.0107 (0.0063) 0.088 - -
Myocardial infarction -0.0073 (0.0148) 0.624 -  -
Angina pectoris -0.0266 (0.0114) 0.020 - -
Congestive heart failure -0.0505 (0.0154) 0.001 - -
Atrial fibrillation -0.0757 (0.0227) 0.001 -0.0751 (0.0247) 0.002
Ischemic stroke -0.0761 (0.0133) < 0.001 -0.0541 (0.0149) < 0.001
Transient ischemic attack -0.0684 (0.0242) 0.005 - -
Cataract -0.0162 (0.0076) 0.034 - -
Retinopathy -0.0217 (0.0093) 0.019 -0.0210 (0.0090) 0.020
Nephropathy -0.0044 (0.0167) 0.794 - -
Data are shown as β coefficients (SEM).Lee WJ, et al.  •  HRQOL in Koreans with Type 2 Diabetes
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for measuring the HRQOL of Korean patients with type 2 dia-
betes. In the final model for utility-weight prediction, BMI, hy-
pertension, angina pectoris, CHF, AF, stroke, TIA, and retinopa-
thy negatively affected the HRQOL of Korean patients with type 
2 diabetes.
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